New perspective on the tissue kallikrein-kinin system in myocardial infarction: role of angiogenesis and cardiac regeneration

International Immunopharmacology
Dirk WestermannCarsten Tschöpe

Abstract

An intensification of the local cardiac kallikrein-kinin system (KKS) is thought to delay the development of cardiac failure. Since myocardial infarction is one of the leading causes of death in the developed countries, the role of the kallikrein-kinin system was studied in numerous experimental studies focusing on this disease using strategies like kallikrein gene transfer, tissue kallikrein infusion and/or by use of human kallikrein over expressing animals. These studies suggested that the kallikrein-kinin system increases coronary blood flow, decreases infarct size and left ventricular remodeling post myocardial infarction. This is of special interest since pharmacological inhibition of the angiotensin converting enzyme acts not only by reducing angiotensin II levels, but also by preventing enzymatic breakdown of kinins, suggesting that the kallikrein-kinin system is part of ACE inhibition effects. Here we review the current concept of the kallikrein-kinin system during myocardial infarction with special regard to its effects on angiogenesis and myocardial regeneration.

References

Dec 1, 1973·The Journal of Experimental Medicine·C G CochraneK D Wuepper
Oct 1, 1994·British Journal of Clinical Pharmacology·J R CockcroftJ M Ritter
Dec 15, 1995·Circulation·P GrovesH Drexler
Aug 4, 1997·The American Journal of Cardiology·K C Wollert, H Drexler
Mar 27, 1999·Journal of Molecular and Cellular Cardiology·N N KimF J Villarreal
Apr 26, 2000·British Journal of Pharmacology·C TschöpeT Walther
Jun 1, 2000·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·C TschöpeT Walther
Oct 12, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·J A SilvaM Bader
Oct 12, 2000·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Y M PintoH Buikema
Jun 16, 2001·Ophthalmologica. Journal international d'ophtalmologie. International journal of ophthalmology. Zeitschrift für Augenheilkunde·S W YangT W Hahn
Jan 24, 2002·Circulation·Costanza EmanueliPaolo Madeddu
Jul 10, 2002·Hypertension·Fabien TraboldPierre Meneton
Jun 21, 2003·American Journal of Physiology. Heart and Circulatory Physiology·Grant BledsoeJulie Chao
Aug 30, 2003·International Immunopharmacology·Caroline LagneuxDaniel Lamontagne
May 1, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Carsten TschöpeMichel Noutsias
Apr 30, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·V Griol-CharhbiliC Richer
Sep 1, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Carsten TschöpeMichel Noutsias
Oct 11, 2005·European Journal of Heart Failure·Dirk WestermannCarsten Tschöpe
Dec 13, 2005·Current Opinion in Nephrology and Hypertension·Frank SpillmannCarsten Tschöpe
Dec 22, 2005·Frontiers in Bioscience : a Journal and Virtual Library·Julie Chao, Lee Chao
Jan 10, 2006·The American Journal of Cardiology·Maria Frigerio, Elena Roubina
Feb 10, 2007·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Cécile CaylaMichael Bader
Jun 19, 2007·Clinical Chemistry·Julie L V Shaw, Eleftherios P Diamandis

❮ Previous
Next ❯

Citations

Oct 7, 2008·Cardiovascular Research·Anton J G Horrevoets
Feb 5, 2009·Kidney International·Masao Kakoki, Oliver Smithies
Feb 18, 2014·Biochemical and Biophysical Research Communications·Herman A SchreuderThorsten Sadowski
Sep 2, 2009·Anais Da Academia Brasileira De Ciências·Maria KouyoumdjianDurval R Borges
Dec 14, 2018·Cells·Miruna Mihaela MicheuMaria Dorobantu
Oct 1, 2009·Physiological Reviews·Carmen ClappGonzalo Martínez De La Escalera
Jan 13, 2018·International Journal of Molecular Medicine·Marina DevetziVassilis Zoumpourlis
Nov 1, 2020·Pharmaceuticals·Suhail HamidNour-Eddine Rhaleb
Jan 9, 2013·Journal of Medicinal Chemistry·Sebastian M SaupeTorsten Steinmetzer
Aug 7, 2012·Journal of Medicinal Chemistry·Sven RufThorsten Sadowski

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiac Regeneration

Cardiac regeneration enables the repair of irreversibly damaged heart tissue using cutting-edge science, including stem cell and cell-free therapy. Discover the latest research on cardiac regeneration here.

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Cardiomegaly

Cardiomegaly, known as an enlarged heart, is a multifactorial disease with different pathophysiological mechanisms. Hypertension, pregnancy, exercise-induced and idiopathic causes are some mechanisms of cardiomegaly. Discover the latest research of cardiomegaly here.

Cardiac Remodeling

Cardiac remodeling in response to a myocardial infarction is characterized by progressive ventricular dilatation, cardiac hypertrophy, fibrosis, and deterioration of cardiac performance. Discover the latest research on Cardiac Remodeling here.

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.